Neumora Therapeutics, Inc. (NMRA) stock
NMRANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 2/30
$0.33−0.03 (-9.47%)
Close on Nov 17, 2026Market cap $62.85MP/E –Yield –
Neumora Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Neumora Therapeutics's market cap was $82.24M on Nov 11, 2026, against $361.75M a year earlier. Over the last 3 years it ranged from $63.84M to $2.80B, with a median of $314.09M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $82.24M | -71.6% |
| 2025 | Dec 31, 2025 | $289.07M | -80.0% |
| 2024 | Apr 30, 2024 | $1.44B | +152.0% |
| 2023 | Dec 29, 2023 | $572.87M | – |
See a number that looks wrong?